Ophthalmology’s lead role in the medical use of artificial intelligence (AI) and its future role in the profession were among the key talking points at the recently concluded RANZCO Scientific Congress. Read more
A new imaging system capable of cancelling out the chromatic aberrations present in a person’s eye promises to provide more accurate assessments of both vision and eye health. Read more
Anti-vascular endothelial growth factor (anti-VEGF) drugs have been identified in breast milk, prompting warnings from the researchers that the use of these medications during breastfeeding could affect developing infants. Read more
Using the same technique that prevents stars from ‘twinkling’ in telescopic images, researchers have captured the first undistorted microscopic images of the trabecular meshwork. Read more
In a development that could lead to new treatments for the condition, a genetic mutation responsible for Bardet-Biedl Syndrome (BBS) has been isolated in monkeys. Read more
The Lions Eye Institute (LEI) has signed a commercial partnership that will combine its antisense gene therapy for a leading cause of childhood blindness with a new Australian-developed drug delivery platform. Read more
A new formulation of the Jetrea intravitreal injection has been listed on Pharmaceutical Benefits Scheme (PBS), replacing the current powder form of the drug. Read more
A new Australian study linking low vitamin D levels with uveitis has suggested investigating whether supplements could help prevent a relapse of the condition in at-risk patients.
Australian research comparing Carl Zeiss’ SITA-Standard and SITA-Faster algorithms has concluded the latter saves time and is just as accurate when testing glaucoma patients, despite producing a higher rate of false-positive results.
Australian researchers are applying artificial intelligence (AI) technology to optical coherence tomography (OCT) scans in a project designed to provide clinicians with more specific details of an eye’s choroidal tissue. Read more